Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c, somatic pseudogene 53 (CYCSP53) is a human pseudogene and not a protein-coding gene. Pseudogenes such as CYCSP53 are typically non-functional remnants of genes that have lost their gene expression capability or protein-coding ability through evolution. CYCSP53 should not be considered a therapeutic target as it does not encode a functional protein, lacks biochemical or biological function, and has no known role in disease, drug interaction, or biomarker utility. Its aliases, including HCP3, refer to the same non-functional gene segment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c, somatic pseudogene 53 (CYCSP53).